[Risks of beta-blockers and calcium inhibitors in amyloid cardiopathy]

Presse Med. 1986 May 24;15(21):981.
[Article in French]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenergic beta-Antagonists / adverse effects*
  • Amyloidosis / drug therapy*
  • Calcium Channel Blockers / adverse effects*
  • Cardiomyopathy, Hypertrophic / drug therapy*
  • Humans
  • Male
  • Middle Aged

Substances

  • Adrenergic beta-Antagonists
  • Calcium Channel Blockers